Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Amanda Coulson"'
Autor:
P A Sanders, Kimme L Hyrich, Kath D. Watson, Bev Harrison, Deborah P M Symmons, Romela Benitha, Peter Klimiuk, Sheila O’Reilly, Nicola Maiden, Shane Clarke, Lianne Kearsley-Fleet, Ian Griffiths, David A. Walsh, Marwan Bukhari, Paul D. Thompson, Ernest Choy, Paul Emery, Rikki Abernethy, Hilary A Capell, Ronald Jubb, Susan Knight, Mark Lunt, Amanda Coulson, Rhian Mair Goodfellow, Tom Price, David Scott, Laura Chadwick, Nina Brown, Andrew Hassell, A J Taggart, Neil Hopkinson, Fiona McCrae, Ian N. Bruce, Sandra Green, Lesley Hordon, George D. Kitas, Kimme L. Hyrich, Duncan Porter
Publikováno v:
BSRBR-RA Control Centre Consortium 2019, ' Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis ', Rheumatology (Oxford) . https://doi.org/10.1093/rheumatology/kez277
BSRBR-RA Control Centre Consortium 2019, ' Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis ', Rheumatology (Oxford, England) . https://doi.org/10.1093/rheumatology/kez277
BSRBR-RA Control Centre Consortium 2019, ' Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis ', Rheumatology (Oxford, England) . https://doi.org/10.1093/rheumatology/kez277
Objectives To compare cervical screening attendance and cytology (high- and low-grade cervical dysplasia [HGCD and LGCD]) between women with RA and the English general population and between biologic DMARD (bDMARD)-naïve and exposed women. Methods T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393fbccc224cacdea428269ea645c5b0
https://research.manchester.ac.uk/en/publications/74caffc6-71d5-4054-9c91-8d6e8426008d
https://research.manchester.ac.uk/en/publications/74caffc6-71d5-4054-9c91-8d6e8426008d
Autor:
W G, Dixon, K L, Hyrich, K D, Watson, M, Lunt, J, Galloway, A, Ustianowski, D P M, Symmons, Amanda, Coulson
Publikováno v:
Annals of the Rheumatic Diseases
BackgroundThe risk of tuberculosis (TB) in patients with rheumatoid arthritis (RA) is thought to be increased following anti-tumour necrosis factor (anti-TNF) therapy, with a proposed differential risk between the anti-TNF drugs etanercept (ETA), inf